Evidence map›Paper›PMID 38092881›Full record

ArticleNature genetics2024

A chromatin-regulated biphasic circuit coordinates IL-1β-mediated inflammation.

Ezio T Fok, Simone J C F M Moorlag, Yutaka Negishi, Laszlo A Groh, Jéssica Cristina Dos Santos, Cathrin Gräwe, Valerie Villacorta Monge, Daphne D D Craenmehr, Mellanie van Roosmalen, David Pablo da Cunha Jolvino and 8 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. IL-1 family cytokines in inflammation and immunity.Cellular & molecular immunology · 2025
    Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 4 countries.

Ezio T FokDepartment of Cell Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen, the Netherlands.ORCID 0000-0001-7427-8644
Simone J C F M MoorlagDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
Yutaka NegishiDepartment of Cell Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen, the Netherlands.ORCID 0000-0002-5134-3957
Laszlo A GrohDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
Jéssica Cristina Dos SantosDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
Cathrin GräweDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University, Nijmegen, the Netherlands.ORCID 0000-0002-3010-8990
Valerie Villacorta MongeLemba Therapeutics, Nijmegen, the Netherlands.
Daphne D D CraenmehrLemba Therapeutics, Nijmegen, the Netherlands.
Mellanie van RoosmalenLemba Therapeutics, Nijmegen, the Netherlands.
David Pablo da Cunha JolvinoAlbert Einstein Research and Education Institute, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Letícia Busato MiglioriniAlbert Einstein Research and Education Institute, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Ary Serpa NetoDepartment of Critical Care Medicine, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Patricia SeverinoAlbert Einstein Research and Education Institute, Hospital Israelita Albert Einstein, São Paulo, Brazil.ORCID 0000-0002-6682-9343
Michiel VermeulenDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University, Nijmegen, the Netherlands.ORCID 0000-0003-0836-6894
Leo A B JoostenDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.ORCID 0000-0001-6166-9830
Mihai G NeteaDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.ORCID 0000-0003-2421-6052
Stephanie FanucchiLemba Therapeutics, Nijmegen, the Netherlands.
Musa M MhlangaDepartment of Cell Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen, the Netherlands. ikigai@mhlangalab.org.ORCID 0000-0003-1381-3409
Radboud University Nijmegen · NLHospital Israelita Albert Einstein · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation is characterized by a biphasic cycle consisting initially of a proinflammatory phase that is subsequently resolved by anti-inflammatory processes. Interleukin-1β (IL-1β) is a master regulator of proinflammation and is encoded within the same topologically associating domain (TAD) as IL-37, which is an anti-inflammatory cytokine that opposes the function of IL-1β. Within this TAD, we identified a long noncoding RNA called AMANZI, which negatively regulates IL-1β expression and trained immunity through the induction of IL37 transcription. We found that the activation of IL37 occurs through the formation of a dynamic long-range chromatin contact that leads to the temporal delay of anti-inflammatory responses. The common variant rs16944 present in AMANZI augments this regulatory circuit, predisposing individuals to enhanced proinflammation or immunosuppression. Our work illuminates a chromatin-mediated biphasic circuit coordinating expression of IL-1β and IL-37, thereby regulating two functionally opposed states of inflammation from within a single TAD.

Indexed as

ChromatinInflammationAnti-Inflammatory AgentsCytokinesHumansInterleukin-1Interleukin-1betaAnti-Inflammatory AgentsChromatinCytokinesIL37 protein, humanInterleukin-1Interleukin-1beta

Identifiers

PMID38092881
OpenAlexW4389676504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.